Research ArticleHuman Studies
Assessing Coronary Artery Disease with Dipyridamole Technetium-99m-Tetrofosmin SPECT: A Multicenter Trial
Zuo-Xiang He, Ami S. Iskandrian, Naresh C. Gupta and Mario S. Verani
Journal of Nuclear Medicine January 1997, 38 (1) 44-48;
Zuo-Xiang He
Ami S. Iskandrian
Naresh C. Gupta


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Assessing Coronary Artery Disease with Dipyridamole Technetium-99m-Tetrofosmin SPECT: A Multicenter Trial
Zuo-Xiang He, Ami S. Iskandrian, Naresh C. Gupta, Mario S. Verani
Journal of Nuclear Medicine Jan 1997, 38 (1) 44-48;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging
- Comparison of Sestamibi, Tetrofosmin, and Q12 Retention in Porcine Myocardium
- Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients
- Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist